Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
113.50    -6.50 (-5.42%)
Bid:
110.00
Ask:
117.00
Spread: 7.00 (6.364%)
Market Cap: £15.31m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

Trading Update

7 Dec 2023 07:00

RNS Number : 9530V
Itaconix PLC
07 December 2023
 

 

For release: 7 December 2023

Itaconix plc

("Itaconix" or the "Company")

Trading Update

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used to decarbonise everyday consumer products, is pleased to provide an update on current trading and outlook, and increased investor relations activities.? 

The Company reports that year-to-date revenue in 2023 is ahead of the same period in 2022.? Unaudited revenues for the full year are expected to be at least $7.7m, with FY2023 earnings expected to be in line with current market expectations.

Our cleaning segment continues to drive overall revenue growth.? In Europe, Itaconix® TSI® detergent polymers are gaining traction as a key ingredient in both private-label and eco-friendly non-phosphate dishwashing detergents.? Revenues from existing North American customers continue to grow from expanded success with retailers and consumers.

Gross profit margins have improved, supported by higher volumes from smaller accounts and beauty products.? The Company anticipates that these favorable gross profit margins will continue into FY2024, aided by reductions in raw material and production costs. The Company expects volumes to continue to grow, with more competitive pricing to customers in FY2024. As a result, revenue expectations are revised to $9.5m or more for FY2024 and $12.5m or more for FY2025, with no change to earnings expectations.

Investor Relations Activities

Itaconix is undertaking additional efforts to boost visibility and attract new investors, both in the UK and internationally, showcasing its accomplishments and growth prospects in the renewable chemicals industry.? In the UK, CEO John Shaw will present at ShareSoc on 28 February 2024 and at Mello2024 in May.? These presentations aim to highlight emerging growth potential and provide a forum for addressing investor enquiries directly.? 

To further improve the accessibility of information about Itaconix, the Company has partnered with ACF Equity Research.? This collaboration will complement existing equity research by adding additional coverage and making it globally available to all investors.? 

Additionally, the Company has engaged Proactive Investors to expand global distribution of information on the Company, with a particular focus on the UK and US. Investors are encouraged to follow coverage of the Company on Proactive Investors: https://www.proactiveinvestors.co.uk/LON:ITX/Itaconix-PLC, as well as Investor Meet Company for the Company's direct communication sessions with investors: https://www.investormeetcompany.com/itaconix-plc/register-investor

John R. Shaw, CEO of Itaconix, commented:?

"As this year closes and a new one shortly begins, Itaconix is gaining momentum with new customers and brands, building a strong foundation of recurring revenue. We are focused on our commercial growth and increasing customer, investor, and consumer awareness of Itaconix's value in everyday products."? 

 

 

Itaconix plc

+1 603 775-4400

John R. Shaw / Laura Denner

Belvedere Communications 

+44 (0)20 7653 8702

John West / Llew Angus

Cavendish Capital Markets Ltd

+44 (0) 20 7220 0500

Nominated Adviser & Joint Broker

Ed Frisby / Abigail Kelly (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

Canaccord Genuity

+44 (0) 20 7523 8000

Joint Broker

Adam James

 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products.? The Company's current ingredients are enabling and leading new generations of products in cleaning, hygiene, and beauty.£ 

www.itaconix.com?

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDGBDDIXGDGXL
Date   Source Headline
2nd Jun 20267:00 amRNSMello 2026 Presentation and Update on Trading
1st Jun 20267:00 amRNS-RProgress in Crop Production Field Trials
29th May 20267:00 amRNS-RDevelopment of Next Generation Plant-Based Paints
27th May 20267:00 amRNS-RLaunch of New Marketing Program for Detergents
14th May 20265:55 pmRNSAdjournment of AGM
6th May 20264:46 pmRNSDirector/PDMR Shareholding
27th Apr 20266:16 pmRNSTR-1
23rd Apr 20267:00 amRNSGrants of Options & PDMR dealings
24th Mar 20267:00 amRNSPreliminary Results
28th Jan 20267:00 amRNSTR-1
16th Jan 20265:29 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSFull Year Trading Update
15th Sep 20257:00 amRNSHalf Year Results
4th Sep 20257:00 amRNSNotice of Interim Results
27th Aug 20258:19 amRNSTR-1
23rd Jul 20257:00 amRNSH1 2025 Trading Update
16th Jul 20257:00 amRNS-RCroda expands agreement: sustainable odour control
1st Jul 20257:00 amRNS-RCommercial Plant-Based Product Launch
8th May 20252:20 pmRNSResult of AGM
6th May 202512:24 pmRNSTR-1
2nd May 20255:28 pmRNSNotice of AGM
1st May 20257:00 amRNSUpdate on US Tariffs
7th Apr 20257:00 amRNSGrants of Options & PDMR dealings
31st Mar 20257:00 amRNSPreliminary Results
18th Mar 20257:00 amRNSNotice of Results and Company Presentation
22nd Jan 20257:00 amRNSTrading Update
5th Nov 20247:00 amRNSTrading Update
10th Oct 20247:00 amRNSChange of Auditor
10th Sep 20247:00 amRNSHalf Year Results
2nd Sep 20247:00 amRNSNotice of Interim Results, Investor Presentation
16th Jul 20247:00 amRNSH1 2024 Trading Update
20th May 20243:03 pmRNSResult of AGM
20th May 20247:00 amRNSAGM Statement and Trading Update
29th Apr 20247:00 amRNSLaunch of two plant-based performance ingredients
19th Apr 20247:00 amRNSGrants of Options & PDMR dealings
15th Apr 20247:00 amRNSPreliminary Results and Notice of AGM
8th Apr 20247:00 amRNSNotice of Results
2nd Apr 20247:00 amRNSTrading Statement
27th Feb 20247:00 amRNSTrading Update
9th Feb 20247:00 amRNSAppointment of Non-Executive Director
26th Jan 20247:00 amRNSAppointment: Nominated Adviser and Sole Broker
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
30th Oct 20237:00 amRNSDirector/PDMR Shareholding
26th Oct 20235:28 pmRNSDirector/PDMR Shareholding
19th Oct 20235:08 pmRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSDirector/PDMR Shareholding
5th Oct 202311:01 amRNSHoldings in Company
12th Sep 20237:00 amRNSHalf year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.